Literature DB >> 16954391

Cytosolic entry controls CD8+-T-cell potency during bacterial infection.

Keith S Bahjat1, Weiqun Liu, Edward E Lemmens, Stephen P Schoenberger, Daniel A Portnoy, Thomas W Dubensky, Dirk G Brockstedt.   

Abstract

Interaction with host immunoreceptors during microbial infection directly impacts the magnitude of the ensuing innate immune response. How these signals affect the quality of the adaptive T-cell response remains poorly understood. Utilizing an engineered strain of the intracellular pathogen Listeria monocytogenes that infects cells but fails to escape from the phagosome, we demonstrate the induction of long-lived memory T cells that are capable of secondary expansion and effector function but are incapable of providing protective immunity. We demonstrate that microbial invasion of the cytosol is required for dendritic cell activation and integration of CD40 signaling, ultimately determining the ability of the elicited CD8+-T-cell pool to protect against lethal wild-type L. monocytogenes challenge. These results reveal a crucial role for phagosomal escape, not for delivery of antigen to the class I major histocompatibility complex pathway but for establishing the appropriate cellular context during CD8+-T-cell priming.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954391      PMCID: PMC1695486          DOI: 10.1128/IAI.01088-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  CD8+ T cell effector mechanisms in resistance to infection.

Authors:  J T Harty; A R Tvinnereim; D W White
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Natural adjuvants: endogenous activators of dendritic cells.

Authors:  S Gallucci; M Lolkema; P Matzinger
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

3.  CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal.

Authors:  O Schulz; A D Edwards; M Schito; J Aliberti; S Manickasingham; A Sher; C Reis e Sousa
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

4.  Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

Authors:  A Rodriguez; A Regnault; M Kleijmeer; P Ricciardi-Castagnoli; S Amigorena
Journal:  Nat Cell Biol       Date:  1999-10       Impact factor: 28.824

5.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5.

Authors:  F Hayashi; K D Smith; A Ozinsky; T R Hawn; E C Yi; D R Goodlett; J K Eng; S Akira; D M Underhill; A Aderem
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

6.  Priming of memory but not effector CD8 T cells by a killed bacterial vaccine.

Authors:  G Lauvau; S Vijh; P Kong; T Horng; K Kerksiek; N Serbina; R A Tuma; E G Pamer
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

7.  Type I interferons produced by dendritic cells promote their phenotypic and functional activation.

Authors:  Maria Montoya; Giovanna Schiavoni; Fabrizio Mattei; Ion Gresser; Filippo Belardelli; Persephone Borrow; David F Tough
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

8.  Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors.

Authors:  Peter Lauer; Man Yin Nora Chow; Martin J Loessner; Daniel A Portnoy; Richard Calendar
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

9.  A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes.

Authors:  G Geginat; S Schenk; M Skoberne; W Goebel; H Hof
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

10.  Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

Authors:  S M Santini; C Lapenta; M Logozzi; S Parlato; M Spada; T Di Pucchio; F Belardelli
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

View more
  39 in total

1.  A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction.

Authors:  Dung T Le; Dirk G Brockstedt; Ran Nir-Paz; Johannes Hampl; Shruti Mathur; John Nemunaitis; Daniel H Sterman; Raffit Hassan; Eric Lutz; Bentley Moyer; Martin Giedlin; Jana-Lynn Louis; Elizabeth A Sugar; Alice Pons; Andrea L Cox; Jordana Levine; Aimee Luck Murphy; Peter Illei; Thomas W Dubensky; Joseph E Eiden; Elizabeth M Jaffee; Daniel A Laheru
Journal:  Clin Cancer Res       Date:  2011-12-06       Impact factor: 12.531

Review 2.  Cancer immunotherapy: a paradigm shift for prostate cancer treatment.

Authors:  Dev Karan; Jeffrey M Holzbeierlein; Peter Van Veldhuizen; J Brantley Thrasher
Journal:  Nat Rev Urol       Date:  2012-05-29       Impact factor: 14.432

Review 3.  Clinical development of Listeria monocytogenes-based immunotherapies.

Authors:  Dung T Le; Thomas W Dubenksy; Dirk G Brockstedt
Journal:  Semin Oncol       Date:  2012-06       Impact factor: 4.929

Review 4.  Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants.

Authors:  Thomas W Dubensky; David B Kanne; Meredith L Leong
Journal:  Ther Adv Vaccines       Date:  2013-11

5.  Early programming of CD8+ T cell response by the orphan nuclear receptor NR4A3.

Authors:  Livia Odagiu; Salix Boulet; Dave Maurice De Sousa; Jean-François Daudelin; Sandrine Nicolas; Nathalie Labrecque
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-10       Impact factor: 11.205

6.  A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3.

Authors:  Admar Verschoor; Michael Neuenhahn; Alexander A Navarini; Patricia Graef; Ann Plaumann; Amelie Seidlmeier; Bernhard Nieswandt; Steffen Massberg; Rolf M Zinkernagel; Hans Hengartner; Dirk H Busch
Journal:  Nat Immunol       Date:  2011-10-30       Impact factor: 25.606

7.  IL-12 and type-I IFN synergize for IFN-gamma production by CD4 T cells, whereas neither are required for IFN-gamma production by CD8 T cells after Listeria monocytogenes infection.

Authors:  Sing Sing Way; Colin Havenar-Daughton; Ganesh A Kolumam; Nural N Orgun; Kaja Murali-Krishna
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

8.  Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.

Authors:  Paulo Cesar Maciag; Matthew M Seavey; Zhen-Kun Pan; Soldano Ferrone; Yvonne Paterson
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

9.  A critical role for phospholipase C in protective immunity conferred by listeriolysin O-deficient Listeria monocytogenes.

Authors:  Nural N Orgun; Sing Sing Way
Journal:  Microb Pathog       Date:  2007-08-11       Impact factor: 3.738

10.  Suppression of cell-mediated immunity following recognition of phagosome-confined bacteria.

Authors:  Keith S Bahjat; Nicole Meyer-Morse; Edward E Lemmens; Jessica A Shugart; Thomas W Dubensky; Dirk G Brockstedt; Daniel A Portnoy
Journal:  PLoS Pathog       Date:  2009-09-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.